HeraMED Limited (ASX:HMD)

Market Cap	47.35M +184.6%
Revenue (ttm)	431.61K -10.3%
Net Income	-4.13M
EPS	-0.00
Shares Out	1.15B
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	195,952
Average Volume	1,575,233
Open	0.0420
Previous Close	0.0420
Day's Range	0.0410 - 0.0420
52-Week Range	0.0060 - 0.0550
Beta	0.15
RSI	41.35
Earnings Date	May 28, 2026

About HeraMED

HeraMED Limited, a medical data and technology company, develops, manufactures, and sells home-based maternity monitoring technology in Australia and the United States. It provides HeraBEAT, a medical device for fetal and maternal heart rate used by pregnant women; and HeraCARE, a digital maternity and women’s health platform that focuses on improving clinical outcomes while supporting more efficient and accessible models of care. The company has a collaboration agreement with Mayo Clinic. HeraMED Limited was founded in 2011 and is based in Haw...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2011
• Country: Australia
• Stock Exchange: Australian Securities Exchange
• Ticker Symbol: HMD

Financial Performance

In 2025, HeraMED's revenue was 431,605, a decrease of -10.31% compared to the previous year's 481,227. Losses were -4.13 million, -24.75% less than in 2024.